Moreover, using the proposed cut-off for mRNA analysis, BCL3 overexpression was consistent in non-tumor adjacent tissues and tumors in the spatial intratumoral analysis, showing its robust potential as a biomarker of diagnosis. The gene discussed is BCL3; the disease is neoplasm.